Debt-to-equity in % of BICYCLE THERAPEUTICS PLC from Q1 2020 to Q3 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Bicycle Therapeutics Plc quarterly Debt-to-equity history and change rate from Q1 2020 to Q3 2025.
  • Bicycle Therapeutics Plc Debt-to-equity for the quarter ending 30 Sep 2025 was 21.8 %, a 30.6% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

BICYCLE THERAPEUTICS PLC Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 21.8 -9.61 -30.6% 30 Sep 2025
Q2 2025 21 -19.8 -48.5% 30 Jun 2025
Q1 2025 20.3 -43.7 -68.3% 31 Mar 2025
Q4 2024 24.7 -44.7 -64.4% 31 Dec 2024
Q3 2024 31.5 -36.6 -53.8% 30 Sep 2024
Q2 2024 40.7 -26.4 -39.3% 30 Jun 2024
Q1 2024 64 +11.3 +21.5% 31 Mar 2024
Q4 2023 69.3 +25.2 +57% 31 Dec 2023
Q3 2023 68 +26.9 +65.6% 30 Sep 2023
Q2 2023 67.1 +23.4 +53.3% 30 Jun 2023
Q1 2023 52.7 +6.45 +14% 31 Mar 2023
Q4 2022 44.2 -6.98 -13.6% 31 Dec 2022
Q3 2022 41.1 -21.1 -33.9% 30 Sep 2022
Q2 2022 43.8 -15.9 -26.6% 30 Jun 2022
Q1 2022 46.2 -14.9 -24.4% 31 Mar 2022
Q4 2021 51.2 -10.7 -17.3% 31 Dec 2021
Q3 2021 62.1 +13.6 +28% 30 Sep 2021
Q2 2021 59.7 +20.8 +53.5% 30 Jun 2021
Q1 2021 61.1 +32.6 +114% 31 Mar 2021
Q4 2020 61.8 31 Dec 2020
Q3 2020 48.5 30 Sep 2020
Q2 2020 38.9 30 Jun 2020
Q1 2020 28.5 31 Mar 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.